Modulation of postoperative immune and inflammatory response by immune-enhancing enteral diet in gastrointestinal cancer patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

420

HTML

3365

Figures (1-3)

380

Tables (1-5)

227

Sum=4392

Jun 15, 2001 (publication date) through Feb 4, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Articles

World J Gastroenterol. Jun 15, 2001; 7(3): 357-362
Published online Jun 15, 2001. doi: 10.3748/wjg.v7.i3.357

Table 1 Characteristics in 2 groups of GI cancer

Characteristics	Supplemented (n = 25)	Control (n = 23)
Age/y	55.2 ± 12.1	52.6 ± 9.8
M/F	16/9	15/8
Site of cancer
Stomach	14	13
Colorectum	8	7
Pancreas	3	3
Type of operation
Gastrectomy (subtotal or total)	14	13
Miles or Dixon procedure	8	7
Pancreatoduodenectomy	3	3
Time of surgery/min	220 ± 45	245 ± 60
Operative blood loss/mL	400 ± 325	450 ± 400
Transfused patients	22	20

Citation: Wu GH, Zhang YW, Wu ZH. Modulation of postoperative immune and inflammatory response by immune-enhancing enteral diet in gastrointestinal cancer patients. World J Gastroenterol 2001; 7(3): 357-362
URL: https://www.wjgnet.com/1007-9327/full/v7/i3/357.htm
DOI: https://dx.doi.org/10.3748/wjg.v7.i3.357